Get the Stockscreener App
0.2906
1.05%
-0.0037
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.2906, with a volume of 1.00M.
It is down -1.05% in the last 24 hours and down -43.52% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.2943
Open:
$0.29
24h Volume:
1.00M
Relative Volume:
0.28
Market Cap:
$20.15M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.4471
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-30.57%
1M Performance:
-43.52%
6M Performance:
-74.23%
1Y Performance:
-77.43%
1-Day Range:
$0.2855
$0.3001
1-Week Range:
$0.2522
$0.32
52-Week Range:
$0.2522
$4.28
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.2906 | 19.52M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.48 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.04 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.78 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
716.41 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
331.36 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. explainedMarket Risk Summary & Daily Profit Focused Stock Screening - newser.com
Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference - Yahoo Finance
When is the best time to exit Reviva Pharmaceuticals Holdings Inc.Global Markets & Stock Timing and Entry Methods - newser.com
How sentiment analysis helps forecast Reviva Pharmaceuticals Holdings Inc. Equity Warrant - newser.com
Is this a good reentry point in Reviva Pharmaceuticals Holdings Inc.Forecast Cut & Fast Entry High Yield Tips - newser.com
Should you wait for a breakout in Reviva Pharmaceuticals Holdings Inc. Equity WarrantGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Comparing Reviva Pharmaceuticals Holdings Inc. in custom built stock radars2025 AllTime Highs & Consistent Return Investment Signals - newser.com
How to escape a deep drawdown in Reviva Pharmaceuticals Holdings Inc.Global Markets & Short-Term High Return Ideas - newser.com
Published on: 2025-09-21 21:45:14 - newser.com
Automated trading signals detected on Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
Published on: 2025-09-20 12:19:44 - newser.com
Insider Sell: Can Reviva Pharmaceuticals Holdings Inc sustain earnings growthJuly 2025 Update & Stepwise Trade Signal Guides - خودرو بانک
Full technical analysis of Reviva Pharmaceuticals Holdings Inc. stock2025 Market Sentiment & Fast Moving Market Watchlists - newser.com
Volatility clustering patterns for Reviva Pharmaceuticals Holdings Inc.Quarterly Trade Review & AI Forecast for Swing Trade Picks - newser.com
Reviva Pharmaceuticals Announces Public Offering to Raise Funds - TipRanks
Smart tools for monitoring Reviva Pharmaceuticals Holdings Inc.’s price action2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Applying big data sentiment scoring on Reviva Pharmaceuticals Holdings Inc. Equity Warrant2025 Volume Leaders & Verified Entry Point Signals - newser.com
Reviva Pharmaceuticals stock plunges after pricing $9 million offering By Investing.com - Investing.com South Africa
Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock retracement – recovery analysisQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Crude Oil Down 1%; Lennar Earnings Miss Views - Benzinga
Reviva Pharmaceuticals stock plunges after pricing $9 million offering - Investing.com
Chart Watch: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant grow without dilution2025 Major Catalysts & Technical Pattern Recognition Alerts - خودرو بانک
Reviva Pharmaceuticals announces public offering of common stock By Investing.com - Investing.com Australia
Why FedEx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering - GlobeNewswire
Reviva Pharmaceuticals (RVPH) Secures $9M in Public Offering - GuruFocus
Reviva Pharmaceuticals prices $9 million public offering - Investing.com
Full Stock Market News from 2025-09-18 - Stock Titan
Reviva Pharmaceuticals prices $9 million public offering By Investing.com - Investing.com UK
$9M Capital Raise: CNS Drug Developer Reviva Pharmaceuticals Prices Stock Offering with Dual Warrants - Stock Titan
Recap Report: How cyclical is Reviva Pharmaceuticals Holdings Inc Equity Warrants revenue stream2025 Technical Patterns & Growth Focused Entry Reports - خودرو بانک
Reviva Pharmaceuticals announces public offering of common stock - Investing.com
Reviva Pharmaceuticals (RVPH) Announces Public Offering to Fund R&D - GuruFocus
Market Review: What analysts say about Reviva Pharmaceuticals Holdings Inc stock2025 Key Highlights & Real-Time Volume Analysis Alerts - خودرو بانک
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewswire
New Highs: What are Airship AI Holdings Incs earnings expectationsWeekly Gains Report & Stepwise Trade Execution Plans - خودرو بانک
Candlestick signals on Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock todayEarnings Overview Report & Precise Trade Entry Recommendations - newser.com
Can Reviva Pharmaceuticals Holdings Inc. hit a new high this monthTrade Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
RSI Check: Is BSBK stock risky to hold nowEarnings Risk Summary & Technical Confirmation Trade Alerts - khodrobank.com
Nasdaq Moves: How do insiders feel about Reviva Pharmaceuticals Holdings IncWeekly Stock Summary & Reliable Breakout Forecasts - خودرو بانک
Fund Flows: Should I invest in Reviva Pharmaceuticals Holdings Inc. before earningsJuly 2025 Analyst Calls & Free High Return Stock Watch Alerts - خودرو بانک
Patterns Watch: Can Yunji Inc Depositary Receipt lead its sector in growth2025 Winners & Losers & AI Powered Buy and Sell Recommendations - خودرو بانک
Can Reviva Pharmaceuticals Holdings Inc. rally from current levelsJuly 2025 Volume & Consistent Profit Trading Strategies - newser.com
What institutional flow reveals about Reviva Pharmaceuticals Holdings Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Real time alert setup for Reviva Pharmaceuticals Holdings Inc. Equity Warrant performanceMarket Growth Report & Fast Momentum Entry Tips - newser.com
Is Liquidity Services Inc. in a consolidation phaseTrade Risk Summary & Growth Focused Entry Point Reports - خودرو بانک
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):